Holen Sie sich die Stockscreener-App
9.66
5.00%
0.46
Schlusskurs vom Vortag:
$9.20
Offen:
$9.81
24-Stunden-Volumen:
6.26M
Relative Volume:
29.76
Marktkapitalisierung:
$9.04M
Einnahmen:
$12.99M
Nettoeinkommen (Verlust:
$-23.72M
KGV:
-0.0993
EPS:
-97.2514
Netto-Cashflow:
$-23.28M
1W Leistung:
+2.88%
1M Leistung:
-56.72%
6M Leistung:
-82.35%
1J Leistung:
-99.46%
1-Tages-Spanne:
$8.10
$9.90
1-Wochen-Bereich:
$7.66
$9.90
52-Wochen-Spanne:
$7.66
$1,868.40
Aptevo Therapeutics Inc Stock (APVO) Company Profile
Firmenname
Aptevo Therapeutics Inc
Sektor
Branche
Telefon
206-838-0500
Adresse
2401 4TH AVE., SEATTLE, WA
Vergleichen Sie APVO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
APVO
Aptevo Therapeutics Inc
|
9.66 | 8.61M | 12.99M | -23.72M | -23.28M | -97.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Aptevo Therapeutics Inc Stock (APVO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2018-11-05 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2017-10-05 | Fortgesetzt | Piper Jaffray | Overweight |
Aptevo Therapeutics Inc Aktie (APVO) Neueste Nachrichten
HOKA Size Guide: What valuation multiples suggest for Aptevo Therapeutics Inc. stockNew Releases Roundup & road comfort picks for daily use - ulpravda.ru
Aptevo Therapeutics shares jump after $60 million equity facility secured - MSN
Aptevo Therapeutics stock jumps after securing $60 million equity line By Investing.com - Investing.com South Africa
Aptevo Therapeutics Secures $60 Million Equity Line of Credit to Support Multispecific Portfolio Advancement, Increase Strategic Optionality - The Globe and Mail
Aptevo secures $60 million equity line of credit to fund operations - Investing.com Nigeria
Aptevo Therapeutics (APVO) Secures $60 Million Equity Line - GuruFocus
Aptevo Therapeutics Secures $60 Million Equity Financing Facility - TipRanks
Aptevo Therapeutics enters equity purchase agreement with YA II PN, Ltd - MarketScreener
Aptevo Therapeutics Signs Standby Equity Purchase Agreement With Yorkville - TradingView — Track All Markets
Biotech lines up $60M to keep next-wave cancer drugs moving to 2029 - Stock Titan
What valuation multiples suggest for Aptevo Therapeutics Inc. stockNew Releases Roundup & road comfort picks for daily use - ulpravda.ru
Aptevo Therapeutics Inc. (APVO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Will Aptevo Therapeutics Inc. (AP81) stock maintain strong growthWeekly Stock Recap & Community Supported Trade Ideas - ulpravda.ru
Will Aptevo Therapeutics Inc. stock deliver shareholder valueEarnings Risk Report & Low Risk High Reward Trade Ideas - ulpravda.ru
Will Aptevo Therapeutics Inc. stock continue upward momentum2025 Top Decliners & Fast Momentum Entry Tips - ulpravda.ru
Is Aptevo Therapeutics Inc. stock a smart buy before Fed meetingPortfolio Performance Summary & Free Verified High Yield Trade Plans - ulpravda.ru
Quarterly Trades: What consensus target says about Aptevo Therapeutics Inc. (AP81) stockCEO Change & Risk Controlled Daily Trade Plans - ulpravda.ru
Is Aptevo Therapeutics Inc. stock a buy for dividend growthRisk Management & Technical Confirmation Trade Alerts - ulpravda.ru
Quarterly Recap: Will Aptevo Therapeutics Inc stock continue upward momentumAnalyst Downgrade & Growth Oriented Trade Recommendations - moha.gov.vn
Aptevo Therapeutics announces 1-for-18 reverse stock split - MSN
Aptevo Therapeutics (APVO) Stock Price, Quote, News & History - Benzinga
Aptevo Therapeutics enacts 1-for-18 reverse stock split, shares to trade on split-adjusted basis By Investing.com - Investing.com Australia
Aptevo Therapeutics enacts 1-for-18 reverse stock split, shares to trade on split-adjusted basis - Investing.com Australia
Aptevo Therapeutics Implements 1-for-18 Reverse Stock Split - TipRanks
Aptevo Therapeutics To Implement 1-for-18 Reverse Stock Split - Nasdaq
Aptevo Therapeutics Inc. (APVO) Stock: Plummets 36% Ahead of 1-for-18 Reverse Split - parameter.io
Aptevo Therapeutics to implement 1-for-18 reverse stock split By Investing.com - Investing.com Australia
Aptevo Therapeutics Stock Slumps To All-Time Low On Reverse Split Approval - Asianet Newsable
Why Aptevo Therapeutics Shares Are Trading Lower By Around 38%? Here Are Other Stocks Moving In Friday's Mid-Day Session - Benzinga
Aptevo Therapeutics (APVO) Announces 1-for-18 Reverse Stock Spli - GuruFocus
Aptevo Therapeutics stock slumps to all-time low on reverse split approval - MSN
What's Going On With Aptevo Therapeutics Stock Today?Aptevo Therapeutics (NASDAQ:APVO) - Benzinga
US Stocks Mixed; Biohaven Shares Fall - Benzinga
Aptevo Therapeutics to implement 1-for-18 reverse stock split - Investing.com
Aptevo Therapeutics stock tumbles after announcing 1-for-18 reverse split - Investing.com India
Aptevo Therapeutics to Conduct 1-for-18 Reverse Stock Split; Shares Fall Pre-Bell - MarketScreener
Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split - standard-journal.com
Aptevo Therapeutics Inc announces 1-for-18 reverse stock split - marketscreener.com
User | chroniclejournal.comAptevo Therapeutics Announces 1-for-18 Reverse Stock Split - FinancialContent
Finanzdaten der Aptevo Therapeutics Inc-Aktie (APVO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):